Canterbury DHB

Context

Salvage Protocols

The main salvage protocols are set out below. Mini BEAM and ESHAP are other alternative salvage regimens that have been used in the past but are not used very often now.

In This Section

ICE-G and IVE-G +/- Rituximab

Vinorelbine and Gemcitabine for Relapsed T-cell NHL or Hodgkin Lymphoma

ICE-G and IVE-G +/- Rituximab

These protocols are used as second or third line treatment for relapsed or refractory aggressive NHL and Hodgkin’s lymphoma. PBSC Harvests can be done during the recovery phase.

Copies of the prescription sheets are available. If stem cell collection is planned after ICE or IVE, both prescription sheets and patient-specific schedules are available.

Vinorelbine and Gemcitabine for Relapsed T-cell NHL or Hodgkin Lymphoma

See Pasricha et al, A Multicenter Phase 2 Study of Risk-adjusted Salvage Chemotherapy Incorporating Vinorelbine and Gemcitabine for Relapsed and Refractory Lymphoma, cancer 2008; 113; 3192-98.

A prescription sheet is available.

Note: Special authority is required for both these agents.

About this Canterbury DHB document (5953):

Document Owner:

Peter Ganly (see Who's Who)

Issue Date:

November 2018

Next Review:

November 2021

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5953